33717152|t|NLRP3 Deficiency Protects Against Intermittent Hypoxia-Induced Neuroinflammation and Mitochondrial ROS by Promoting the PINK1-Parkin Pathway of Mitophagy in a Murine Model of Sleep Apnea.
33717152|a|Obstructive sleep apnea (OSA) associated neurocognitive impairment is mainly caused by chronic intermittent hypoxia (CIH)-triggered neuroinflammation and oxidative stress. Previous study has demonstrated that mitochondrial reactive oxygen species (mtROS) was pivotal for hypoxia-related tissue injury. As a cytosolic multiprotein complex that participates in various inflammatory and neurodegenerative diseases, NLRP3 inflammasome could be activated by mtROS and thereby affected by the mitochondria-selective autophagy. However, the role of NLRP3 and possible mitophagy mechanism in CIH-elicited neuroinflammation remain to be elucidated. Compared with wild-type mice, NLRP3 deficiency protected them from CIH-induced neuronal damage, as indicated by the restoration of fear-conditioning test results and amelioration of neuron apoptosis. In addition, NLRP3 knockout mice displayed the mitigated microglia activation that elicited by CIH, concomitantly with elimination of damaged mitochondria and reduction of oxidative stress levels (malondialdehyde and superoxide dismutase). Elevated LC3 and beclin1 expressions were remarkably observed in CIH group. In vitro experiments, intermittent hypoxia (IH) significantly facilitated mitophagy induction and NLRP3 inflammasome activation in microglial (BV2) cells. Moreover, IH enhanced the accumulation of damaged mitochondria, increased mitochondrial depolarization and augmented mtROS release. Consistently, NLRP3 deletion elicited a protective phenotype against IH through enhancement of Parkin-mediated mitophagy. Furthermore, Parkin deletion or pretreated with 3MA (autophagy inhibitor) exacerbated these detrimental actions of IH, which was accompanied with NLRP3 inflammasome activation. These results revealed NLRP3 deficiency acted as a protective promotor through enhancing Parkin-depended mitophagy in CIH-induced neuroinflammation. Thus, NLRP3 gene knockout or pharmacological blockage could be as a potential therapeutic strategy for OSA-associated neurocognitive impairment.
33717152	0	5	NLRP3	Gene	216799
33717152	47	54	Hypoxia	Disease	MESH:D000860
33717152	63	80	Neuroinflammation	Disease	MESH:D000090862
33717152	85	98	Mitochondrial	Disease	MESH:D028361
33717152	99	102	ROS	Chemical	MESH:D017382
33717152	120	125	PINK1	Gene	68943
33717152	159	165	Murine	Species	10090
33717152	175	186	Sleep Apnea	Disease	MESH:D012891
33717152	188	211	Obstructive sleep apnea	Disease	MESH:D020181
33717152	213	216	OSA	Disease	MESH:D020181
33717152	229	254	neurocognitive impairment	Disease	MESH:D019965
33717152	275	303	chronic intermittent hypoxia	Disease	MESH:D000860
33717152	305	308	CIH	Disease	MESH:D000860
33717152	320	337	neuroinflammation	Disease	MESH:D000090862
33717152	397	410	mitochondrial	Disease	MESH:D028361
33717152	411	434	reactive oxygen species	Chemical	MESH:D017382
33717152	436	441	mtROS	Chemical	-
33717152	459	466	hypoxia	Disease	MESH:D000860
33717152	475	488	tissue injury	Disease	MESH:D017695
33717152	555	567	inflammatory	Disease	MESH:D007249
33717152	572	598	neurodegenerative diseases	Disease	MESH:D019636
33717152	600	605	NLRP3	Gene	216799
33717152	641	646	mtROS	Chemical	-
33717152	730	735	NLRP3	Gene	216799
33717152	772	775	CIH	Disease	MESH:D000860
33717152	785	802	neuroinflammation	Disease	MESH:D000090862
33717152	852	856	mice	Species	10090
33717152	858	863	NLRP3	Gene	216799
33717152	895	898	CIH	Disease	MESH:D000860
33717152	907	922	neuronal damage	Disease	MESH:D009410
33717152	1041	1046	NLRP3	Gene	216799
33717152	1056	1060	mice	Species	10090
33717152	1123	1126	CIH	Disease	MESH:D000860
33717152	1225	1240	malondialdehyde	Chemical	MESH:D008315
33717152	1277	1280	LC3	Gene	66734
33717152	1285	1292	beclin1	Gene	56208
33717152	1333	1336	CIH	Disease	MESH:D000860
33717152	1379	1386	hypoxia	Disease	MESH:D000860
33717152	1388	1390	IH	Disease	MESH:D000860
33717152	1442	1447	NLRP3	Gene	216799
33717152	1487	1490	BV2	CellLine	CVCL:0182
33717152	1509	1511	IH	Disease	MESH:D000860
33717152	1573	1586	mitochondrial	Disease	MESH:D028361
33717152	1616	1621	mtROS	Chemical	-
33717152	1645	1650	NLRP3	Gene	216799
33717152	1700	1702	IH	Disease	MESH:D000860
33717152	1801	1804	3MA	Chemical	-
33717152	1868	1870	IH	Disease	MESH:D000860
33717152	1899	1904	NLRP3	Gene	216799
33717152	1953	1958	NLRP3	Gene	216799
33717152	2048	2051	CIH	Disease	MESH:D000860
33717152	2060	2077	neuroinflammation	Disease	MESH:D000090862
33717152	2085	2090	NLRP3	Gene	216799
33717152	2182	2185	OSA	Disease	MESH:D020181
33717152	2197	2222	neurocognitive impairment	Disease	MESH:D019965
33717152	Association	MESH:D000090862	216799
33717152	Positive_Correlation	MESH:D000860	66734
33717152	Association	MESH:D019965	216799
33717152	Positive_Correlation	MESH:D000860	56208
33717152	Association	216799	68943
33717152	Negative_Correlation	MESH:D008315	MESH:D000860
33717152	Association	MESH:D000860	216799
33717152	Association	MESH:D028361	216799
33717152	Association	MESH:D017382	MESH:D017695
33717152	Association	MESH:D017382	MESH:D000860
33717152	Association	MESH:D009410	216799
33717152	Association	MESH:D028361	68943
33717152	Association	MESH:D019636	216799
33717152	Association	MESH:D017382	68943

